New Delhi, Feb. 17, 2025 (GLOBE NEWSWIRE) -- The global clinical data management system market was valued at US$ 4.08 billion in 2024 and is expected to reach US$ 10.35 billion by 2033, growing at a ...

In the dynamic environment of biotechnology trials, the significance of Clinical Data Management systems (CDMs) cannot be overstated. As we navigate the complexities of these trials and the pivotal ...

Surge in Clinical Trials: The pharmaceutical and biotechnology industries are experiencing an unprecedented rise in clinical trials due to increased R&D investments and growing disease prevalence.

The clinical data management systems market is expected to grow at a robust CAGR of 12% from 2025 to 2030. This growth is driven by the rising number of global clinical trials, stringent regulatory ...

US-based clinical data exchange company MRO has acquired Q-Centrix, an enterprise clinical data management platform previously owned by TPG Growth. Q-Centrix is a comprehensive data management ...

MILWAUKEE, WI, November 19, 2024 (EZ Newswire) -- As biopharmaceutical sponsors face increasing challenges in securing investigative sites for their clinical trials, the ability to reduce ...

The clinical data management systems market is expected to grow at a robust CAGR of 12% from 2025 to 2030. This growth is driven by the rising number of global clinical trials, stringent regulatory ...

Veeva Systems Inc. VEEV recently announced the availability of a novel solution for aggregating, cleaning and transforming clinical data, Veeva CDB (clinical database). The new clinical data ...

Gartner identifies healthcare supply chain trends for 2025, highlighting clinical collaboration, cost management, and digital transformation.

DUBLIN--(BUSINESS WIRE)--The "Growth Opportunities in Clinical Trial Data Management and eClinical Solutions Market, Forecast to 2020" report has been added to ResearchAndMarkets.com's offering. The ...

(MENAFN- GlobeNewsWire - Nasdaq) Clinical data management systems (CDMS) market is rapidly growing, driven by rising clinical trial complexity, AI integration, decentralized trials, regulatory ...